Abstract:Shaoguang Li, 1 Zhan Lin, 1 Haobo Chen, 1 Qiu Luo, 1 Shengnan Han, 1 Kunlong Huang, 1 Ruichan Chen, 1 Yuying Zhan, 1 Bing Chen, 2 Hong Yao 1– 3 1 Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, FuJian, People's Republic of China; 2 Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Fujian Medical University, Fuzhou, Fujian, People's Republic of China; 3 Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Fujian Medical University, Fuzhou, Fujian, People's Republic of China Correspondence: Shaoguang Li; Hong Yao, Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, 1 Xue Yuan Road, University Town, Fuzhou, Fujian, 350122, People's Republic of China, Email ; Background: The preclinical diagnosis of tumors is of great significance to cancer treatment. Near-infrared fluorescence imaging technology is promising for the in-situ detection of tumors with high sensitivity. Methods: Here, a fluorescent probe was synthesized on the basis of Au nanoclusters with near-infrared light emission and applied to fluorescent cancer cell labeling. Near-infrared methionine-N-Hydroxy succinimide Au nanoclusters (Met-NHs-AuNCs) were prepared successfully by one-pot synthesis using Au nanoclusters, methionine, and N-Hydroxy succinimide as frameworks, reductants, and stabilizers, respectively. The specific fluorescence imaging of tumor cells or tissues by fluorescent probe was studied on the basis of SYBYL Surflex-DOCK simulation model of LAT1 active site of overexpressed receptor on cancer cell surface. The results showed that Met-NHs-AuNCs interacted with the surface of LAT1, and C_Score scored the conformation of the probe and LAT1 as five. Results: Characterization and in vitro experiments were conducted to explore the Met-NHs-AuNCs targeted uptake of cancer cells. The prepared near-infrared fluorescent probe (Met-NHs-AuNCs) can specifically recognize the overexpression of L-type amino acid transporter 1 (LAT1) in cancer cells so that it can show red fluorescence in cancer cells. Meanwhile, normal cells (H9c2) have no fluorescence. Conclusion: The fluorescent probe demonstrates the power of targeting and imaging cancer cells. Keywords: Au nanoclusters, fluorescence imaging, cancer cell imaging, molecular docking Epidemiological studies have shown that the incidence and mortality of cancer have been increasing in recent decades. 1,2 Thus, the early screening of people who are at high risk of cancer can detect tumors in time and increase their chances of receiving treatment and cure. 3 Therefore, the use of sensitive and specific detection techniques to locate solid tumors is the first and indispensable step in the treatment of cancer patients. 4 With the continuous development of optical imaging technology for decades, it has been widely used in the preclinical diagnosis and treatment of cancer in biomedical research. 5–8 Nanomaterials for optical imaging, such as nano clusters, 9 silicon dioxide, carbon dots and magnetic materials, 10,11 have always been the focus of cancer diagnosis research because of their uniqueness. 12 The intrinsic optical properties of nanoparticles make them quickly become the best choice for various cell imaging modes. 13 Nanoparticles usually combine with suitable targeted ligands on the particle surface to form luminescent materials with different emission wavelengths because of their high sensitivity, small size, and composition. Among them, Au nanoclusters (AuNCs) have become a hot research fields of cancer cell imaging applications because of their ultra-fine size, biocompatibility (eg, bioinertia and low cytotoxicity), 14 unique and highly adjustable optical properties, and photostability. However, the most challenging issues for large-scale application of imaging Au nanoclusters of cancer cells are their specificity and sensitivity. In tumor diagnosis, distinguishing cancer cells from normal cells accurately is very important. 15,16 To improve the sensitivity and selectivity of tumor imaging, it is the most ideal method to develop targeted tumor fluorescent imaging materials that can specifically recognize the entry of overexpressed receptors into tumor cells. In recent years, a variety of functional small molecule dyes have been developed for specific targeted fluorescence imaging of specific tissues or receptors. 17–22 For example, Wang et al successfully synthesized a CP-IRT Nir-II molecular imaging probe with high affinity an -Abstract Truncated-

Synthesis of a Novel IR-822-Met Near-Infrared Probe for in Vivo Tumor Diagnosis

Methionine-Decorated Near Infrared Fluorescent Probe for Prolonged Tumor Imaging.

Synthesis of a Novel L -Methyl-methionine–icg-der-02 Fluorescent Probe for in Vivo Near Infrared Imaging of Tumors

A Novel Near-Infrared Theranostic Probe for Accurate Cancer Chemotherapy in Vivo by a Dual Activation Strategy

Novel Dual-Function Near-Infrared II Fluorescence and PET Probe for Tumor Delineation and Image-Guided Surgery.

Molecular Cancer Imaging in the Second Near‐Infrared Window Using a Renal‐Excreted NIR‐II Fluorophore‐Peptide Probe

Novel Benzo-Bis(1,2,5-thiadiazole) Fluorophores for in Vivo NIR-II Imaging of Cancer

Synthesis of Dimeric Cyclic RGD Based Near-Infrared Probe for in Vivo Tumor Diagnosis

Design and Synthesis of Novel Near-Infrared Fluorescence Probes Based on an Open Conformation of a Cytochrome P450 1B1 Complex for Molecular Imaging of Colorectal Tumors.

A Near-Infrared Fluorescent Heptamethine Indocyanine Dye With Preferential Tumor Accumulation For In Vivo Imaging

An Antigen-Strengthened Dye-Modified Fully-Human-nanobody-based Immunoprobe for Second Near Infrared Bioimaging of Metastatic Tumors

Discovery of Near-Infrared Heptamethine Cyanine Probes for Imaging-Guided Surgery in Solid Tumors

A novel NIR-II nanoprobe for precision imaging of micro-meter sized tumor metastases of multi-organs and skin flap

Molecular Engineering of a Commercially Available NIR-II Fluorescent Cyanine Dye for Improved Tumor Targeting and Imaging

A Near-Infrared Multifunctional Fluorescent Probe With An Inherent Tumor-Targeting Property For Bioimaging

Design, Synthesis and in Vivo Fluorescence Imaging Study of a Cytochrome P450 1B1 Targeted NIR Probe Containing a Chelator Moiety

Near-infrared fluorescent probe, multi-modal nano contrast agent based on near-infrared fluorescent probe, and preparation and application thereof

Development of a Novel Melatonin-Modified Near-Infrared Fluorescent Probe for in Vivo Hepatocellular Carcinoma Imaging

Synthesis of a near-infrared fluorescent probe and its application in imaging of MCF-7 cells

Synthesis and Application of a Near-Infrared Light-Emitting Fluorescent Probe for Specific Imaging of Cancer Cells with High Sensitivity and Selectivity

Tumor-homing Peptide-Based NIR-II Probes for Targeted Spontaneous Breast Tumor Imaging